Work

Supplementary Table Legend from A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission

Year: 2023
Type: supplementary-materials
Abstract: PDF file - 44K
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361884265
Cites:
Cited by:
Related to: 10